Cell Source, Inc.
CLCS
$0.25
-$0.02-7.41%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.13M | 2.14M | 2.31M | 2.60M | 2.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.03M | 4.19M | 3.91M | 4.18M | 4.39M |
| Operating Income | -4.03M | -4.19M | -3.91M | -4.18M | -4.39M |
| Income Before Tax | -5.23M | -5.15M | -4.91M | -5.32M | -5.61M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.23 | -5.15 | -4.91 | -5.32 | -5.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.23M | -5.15M | -4.91M | -5.32M | -5.61M |
| EBIT | -4.03M | -4.19M | -3.91M | -4.18M | -4.39M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.16 | -0.16 | -0.16 | -0.17 | -0.18 |
| Normalized Basic EPS | -0.08 | -0.08 | -0.08 | -0.09 | -0.10 |
| EPS Diluted | -0.16 | -0.16 | -0.16 | -0.17 | -0.18 |
| Normalized Diluted EPS | -0.08 | -0.08 | -0.08 | -0.09 | -0.10 |
| Average Basic Shares Outstanding | 162.62M | 158.39M | 154.58M | 151.13M | 147.72M |
| Average Diluted Shares Outstanding | 162.62M | 158.39M | 154.58M | 151.13M | 147.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |